Home> Industry News > All

Spotlight – Many questions and few answers after Esmo’s Checkmate debacle

Trendepvantage2017-09-21 12:24Read   0

In the controversy over the abbreviated presentation of results from Checkmate-214 at an Esmo press conference there has been little chance to examine the questions posed by the kidney cancer study’s surprising results.

Scientists restore tumour-fighting structure to mutated breast cancer proteins

Healthecancer2017-09-21 12:24Read   0

Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time.

China’s WuXi, Johnson & Johnson-backed XW Labs lands $17.5M series B

EVENTSfiercebiotech2017-09-21 10:56Read   0

Chinese neurological disorders startup XW Laboratories has seen a $17.5 million series B, bumping up its total raise from its first round to $23 million.

Glythera taps Iontas for antibodies to guide next-generation ADCs

R&Dfiercebiotech2017-09-21 10:56Read   0

Glythera has struck a deal to access a source of antibodies against specified targets. Iontas will use its phage display libraries and other antibody discovery capabilities to provide Glythera with a key component of its planned antibody drug conjugates (ADCs).

Fat-regulating enzyme could hold the key to obesity, diabetes, cancer, other diseases

Healthecancer2017-09-20 13:36Read   0

scientists at Rutgers University-New Brunswick have now found that getting rid of the enzyme entirely can increase the risk of cancer, inflammation and other ills.

Teva offloads women's health unit in quickfire deals

Trendpmlive2017-09-20 13:36Read   0

Teva has announced two deals in quick succession to sell off the entirety of its women's health business assets, raising almost $2.5bn that will go towards paying off its debts.

Roche says Venetoclax combination improves PFS in phase III CLL trial

R&Dclinicaltrials2017-09-20 13:36Read   1

Roche has reported that its cancer drug Venclexta/Venclyxto (venetoclax), developed jointly with AbbVie, has succeeded in a phase 3 study in chronic lymphocytic leukaemia (CLL) patients by meeting its primary endpoint.

FDA clears Medtronic's next-generation spinal cord stimulator

Trendfiercebiotech2017-09-20 13:36Read   1

The FDA cleared Medtronic's latest spinal cord stimulation system for the treatment of chronic intractable pain. The world's smallest SCS, the Intellis device offers activity tracking and personalized pain relief.

Cancer Treatment Can Affect Your Food Preferences

Trenddrugs2017-09-20 13:36Read   0

Cancer therapies often change patients' sense of taste, which may affect what they like to eat, according to a nutrition expert.

How bacteria hinder chemotherapy

Trendecancer2017-09-20 13:36Read   1

To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published in Science, researchers describe findings that certain bacteria can be found inside human pancreatic tumours.

CHMP backs maintenance therapy for Tesaro's Zejula

Trendpmlive2017-09-19 13:37Read   1

Swiss biotech Tesaro has picked up a CHMP recommendation for its PARP inhibitor Zejula as a maintenance therapy for ovarian cancer, upping the ante in its rivalry with AstraZeneca and Clovis Oncology.

Gates invests in Immunocore to spur infectious disease R&D

EVENTSfiercebiotech2017-09-19 13:37Read   0

The Bill & Melinda Gates Foundation is investing up to $40 million in Immunocore to spur research into the use of T cell receptor (TCR)-based therapeutics to treat tuberculosis and HIV.

First Prev 1 2 3 4 Next Last GO
You may interest
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top